Keep fighting to lower the cost of prescription drugs.

Emanuel Cleaver · Missouri · Democratic

policy impact 0.78 specificity 0.70 extraction confidence 87%

Contest this claim

Occurrences

Evidence

Congressional Record Index entry for Emanuel Cleaver lists H.R. 7391 and H.R. 4317 among the bills associated with him in the 119th Congress, 2nd Session. H.R. 7391 is the Community Health Center Drug Pricing Protection Act, and another indexed item is the Pharmacy Benefit Manager (PBM) Reform Act.

Recent official congressional indexing shows Cleaver connected to drug-pricing-related legislation, including PBM reform, but it does not show enactment or a completed reduction in prescription drug costs.

unresolved same_term A for effort

CRI2026 - CLEAVER, EMANUEL (a Representative from Missouri) - CRI-2026-CLEAVER-EMANUEL-BE8E6 | Content Details | GovInfo
secondary · model gpt-5.4-mini · confidence 74%

Contest this evidence item

The bill page shows H.R. 7391, introduced in the House on February 5, 2026, with Emanuel Cleaver listed among the bill's supporters/cosponsors and referral to the Committee on Energy and Commerce. The measure addresses drug pricing for community health centers by limiting covered outpatient drug prices to the 340B ceiling price at purchase.

Cleaver took a concrete legislative step aligned with lowering prescription drug costs, but the bill was only introduced and referred, not enacted.

unresolved same_term A for effort

H.R. 7391 (IH) - Community Health Center Drug Pricing Protection Act - BILLS-119hr7391ih | Content Details | GovInfo
secondary · model gpt-5.4-mini · confidence 78%

Contest this evidence item

Assessments

delivered same_term A for effort

The promise was framed as continuing to fight for lower prescription drug costs, not guaranteeing enactment of a specific bill or a measurable price reduction. In the same federal office context, Cleaver is credited with concrete aligned legislative activity, including support for drug-pricing-related measures such as H.R. 7391 and PBM reform efforts. The cited evidence does not show those 119th Congress bills becoming law or independently proving lower costs, so the delivery rests on fulfilling the advocacy/action promise rather than completing a specific policy outcome.

provider codex_cli · model gpt-5.5 · confidence 76%